Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Gliosarcoma 8Prostatic Neoplasms 7Glioblastoma 7Squamous Cell Carcinoma of Head and Neck 5Lung Neoplasms 5Breast Neoplasms 4Brain Neoplasms 4Sarcoma 3Astrocytoma 3Wilms Tumor 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Central Nervous System Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1

Interventions

Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Endometrial Serous Adenocarcinoma × Radiotherapy, Conformal × Clear all
NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
4 enrolled 6 charts
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡